UL Prospector
Prospector

CelluCap™ C

  • Empresa:

    Tagra Biotechnologies Ltd.

  • INCI Name:

    Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate (and) Cellulose Acetate Butyrate (and) Ascorbyl Tetraisopalmitate

CelluCap™ C is a highly effective encapsule of Ascorbyl Tetraisopalmitate, which helps overcome common formulation challenges associated with Vitamin C. By isolating this oil-soluble Vitamin C derivative, formulations are less likely to show discoloration and deterioration of the raw material. It is as if each micro-dose of Ascorbyl Tetraisopalmitate is delivered in its own airtight packaging. CelluCap™ C exhibits Tagra's Release on Demand (RND) technology, which releases the Ascorbyl Tetraisopalmitate only upon mechanical application. The cellulose based shell collapses, releasing the active while breaking down into invisible particles. These particles retain some of the core ingredients, creating an extended delivery for continued efficacy.

Upgrade to Prospector Premium to view Compliance Highlights Obtener más información

Retailer Compliance Status

No retailer information is available at this time.

Regulatory & Advisory Status

No hay información normativa disponible en este momento.

Compliance information powered by UL's ChemADVISOR™ Regulatory Database.

Empresa

Tagra Biotechnologies, since its inception in 1998, focuses on developing and manufacturing microencapsulated ingredients such as actives, pigments, essential oils, UV filters, and highly water-soluble ingredients.

Tagra is the first to patent a unique innovative Release on Demand™ (RND™) Microencapsulation Technology. Tagra’s platform addresses industry challenges of stability, efficiency, and compatibility with other cosmetic and pharmaceutical formulation ingredients. The technology enables the masking, protecting, and releasing of more than 40 actives and pigments widely used in cosmetics and OTC preparations. Tagra’s microcapsules are friction released through consumer applications.

Tagra also owns and operates its own plant and state-of-the-art laboratory meeting all required regulations.

Documentos de la Empresa

La información presentada aquí fue adquirida por UL desde el productor del material. UL hace un esfuerzo considerable para asegurar la exactitud de estos datos. Sin embargo, UL no asume responsabilidad por los valores de los datos y alienta firmemente a que tras la selección final del material, los puntos de los datos sean validados con el proveedor de la materia

Tagra Biotechnologies Ltd. hacer su documentación disponible en las siguiente/s región/es

Donde Comprar

Tagra Biotechnologies Ltd.

Es usted un distribuidor que esta interesado en aparecer listado aquí? Por favor contáctenos!